about
Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing dru...
Read More
2.12
0.01
(0.47%)
29,434
XNAS Volume
XNAS 31 Jul, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Lipocine Inc is on 05 Aug 2026 for the purpose of Lipocine Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Lipocine Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..